Single-arm trials for cancer drug approval and patient access

被引：0
|
作者：
Martinalbo, J. [1 ]
Camarero, J. [2 ]
Delgado-Charro, B. [1 ]
Demolis, P. [3 ]
Ersboll, J. [4 ]
Foggi, P. [5 ]
Jonsson, B. [6 ]
O'Connor, D. [7 ]
Pignatti, F. [8 ]
机构：
[1] EMA, R&D Support Div, London, England
[2] Spanish Agcy Med & Healthcare Prod AEMPS, Oncol Drug Evaluat, Madrid, Spain
[3] French Natl Agcy Med & Hlth Prod Safety ANSM, Strategy, Paris, France
[4] Danish Med Agcy DKMA, Licensing, Copenhagen, Denmark
[5] Italian Med Agcy AIFA, Licensing, Rome, Italy
[6] Swedish Med Prod Agcy MPA, Licensing, Uppsala, Sweden
[7] Med & Healthcare Prod Regulatory Agcy MHRA, Licensing, London, England
[8] EMA, Oncol Haematol & Diagnost, London, England
来源：
ANNALS OF ONCOLOGY | 2016年 / 27卷
关键词：
D O I：
10.1093/annonc/mdw435.49
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
1362O_PR
引用
收藏
页数：1
相关论文
共 50 条
  • [1] Single-arm trials for US Food and Drug Administration cancer drug approvals
    Nierengarten, Mary Beth
    [J]. CANCER, 2023, 129 (11) : 1626 - 1627
  • [2] Use of Single-Arm Trials for US Food and Drug Administration Drug Approval in Oncology, 2002-2021
    Agrawal, Sundeep
    Arora, Shaily
    Amiri-Kordestani, Laleh
    de Claro, R. Angelo
    Fashoyin-Aje, Lola
    Gormley, Nicole
    Kim, Tamy
    Lemery, Steven
    Mehta, Gautam U.
    Scott, Emma C.
    Singh, Harpreet
    Tang, Shenghui
    Theoret, Marc R.
    Pazdur, Richard
    Kluetz, Paul G.
    Beaver, Julia A.
    [J]. JAMA ONCOLOGY, 2023, 9 (02) : 266 - 272
  • [3] The Value of Patient-Reported Outcomes in Single-Arm Cancer Trials
    Di Maio, Massimo
    [J]. CANCER INVESTIGATION, 2023, 41 (05) : 491 - 494
  • [4] Single-arm trials for domestic oncology drug approvals in China
    Zhang, Hong
    Liu, Sen
    Ge, Chenghao
    Liu, Xiaozhen
    Liu, Yang
    Yin, Chen
    Li, Yi
    An, Jing
    Yan, Zhongtian
    Chen, Xiaoyuan
    [J]. CANCER BIOLOGY & MEDICINE, 2023, 20 (11) : 799 - 805
  • [5] Single-arm trials for domestic oncology drug approvals in China
    Hong Zhang
    Sen Liu
    Chenghao Ge
    Xiaozhen Liu
    Yang Liu
    Chen Yin
    Yi Li
    Jing An
    Zhongtian Yan
    Xiaoyuan Chen
    [J]. Cancer Biology & Medicine, 2023, (11) : 799 - 805
  • [6] Increasing FDA-accelerated approval of single-arm trials in oncology (1992 to 2020)
    Ribeiro, Tatiane Bomfim
    Bennett, Charles L.
    Colunga-Lozano, Luis Enrique
    Araujo, Ana Paula Vieira
    Hozo, Iztok
    Djulbegovic, Benjamin
    [J]. JOURNAL OF CLINICAL EPIDEMIOLOGY, 2023, 159 : 151 - 158
  • [7] NICE RECONSIDERATION FOR ONCOLOGY DRUGS BASED ON SINGLE-ARM TRIALS REFERRED TO CANCER DRUG FUND
    Wu, S.
    Zou, D.
    Zhang, E.
    [J]. VALUE IN HEALTH, 2024, 27 (06) : S119 - S119
  • [8] Single-Arm Clinical Trials as Pivotal Evidence for Cancer Drug Approval: A Retrospective Cohort Study of Centralized European Marketing Authorizations Between 2010 and 2019
    Tenhunen, Olli
    Lasch, Florian
    Schiel, Anja
    Turpeinen, Miia
    [J]. CLINICAL PHARMACOLOGY & THERAPEUTICS, 2020, 108 (03) : 653 - 660
  • [9] Alternate statistical tools and limitations in genetic marker association studies in single-arm drug cancer trials
    Owzar, Kouros
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (09) : 1400 - 1401
  • [10] Do single-arm trials have a role in drug development plans incorporating randomised trials?
    Grayling, Michael J.
    Mander, Adrian P.
    [J]. PHARMACEUTICAL STATISTICS, 2016, 15 (02) : 143 - 151
12345